AIR FACTORY® (PMTA) Premarket Tobacco Application Moves Into FDA Substantive Scientific Review
Press release content from Business Wire. The AP news staff was not involved in its creation.
IRVINE, Calif.–(BUSINESS WIRE)–Oct 15, 2020–
My Vape Order, Inc. (MVO), a trusted provider of nicotine e-liquid products marketed under the AIR FACTORY® brand, has announced that on October 9, 2020, the U.S. Food and Drug Administration (FDA) issued a Filing Letter notifying MVO that the AIR FACTORY® Premarket Tobacco Application (PMTA) met FDA’s PMTA filing requirements and was moving forward into FDA’s substantive scientific review phase.
This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20201015005777/en/
PMTA Tracker (Graphic: Business Wire)
MVO’s CEO, Kyle Godfrey, commented, “[i]n this critical phase, FDA will review the extensive scientific data and research submitted with the AIR FACTORY® PMTA to determine whether the AIR FACTORY® products consumers know and love are ‘appropriate for the protection of public health’ – the standard that FDA considers when deciding which products to allow for sale. The AIR FACTORY® PMTA was the culmination of years of planning and extensive toxicological testing and scientific research. We look forward to working with FDA on its review of the AIR FACTORY® products, with the ultimate goal of obtaining FDA marketing orders for the products.” Godfrey noted that the company would continue to provide updates regarding FDA’s PMTA review of the AIR FACTORY® products.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201015005777/en/
CONTACT: Bill Dully, President, COO
bill@myvapeorder.com, (949) 396-1428
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: ONLINE RETAIL RETAIL FDA HEALTH TOBACCO SPECIALTY
SOURCE: My Vape Order, Inc.
Copyright Business Wire 2020.
PUB: 10/15/2020 11:33 AM/DISC: 10/15/2020 11:33 AM
http://www.businesswire.com/news/home/20201015005777/en